Junshi Biosciences
Public 1877.HK · China
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
7
in active trials
Trials
13 active
14 since 2021
Drugs7
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | 31 Dec 2027Phase 2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Advanced Malignant Solid Tumors, Triple-negative Breast Cancer | ||||
| Open drug page | |||||
PD-1/VEGF bispecific antibody |
Phase 3 | 27 Nov 2026soonPhase 2 trial completes | |||
| How it works | A cancer drug that hits two targets at once | ||||
| Next date | 27 Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Advanced Malignant Solid Tumors, Hepatocellular Carcinoma and 8 more | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Dec 2027Phase 2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma | ||||
| Open drug page | |||||
— |
Phase 2 | 27 Nov 2026soonPhase 2 trial completes | |||
| Next date | 27 Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Advanced Colorectal Cancer | ||||
| Open drug page | |||||
— |
Phase 2 | 30 Nov 2027Phase 2 trial completes | |||
| Next date | 30 Nov 2027 · Phase 2 trial completes | ||||
| Also tested for | Non-squamous Non-small Cell Lung Cancer, Advanced Lung Cancer and 3 more | ||||
| Open drug page | |||||
— |
Phase 2 | 30 Nov 2027Phase 2 trial completes | |||
| Next date | 30 Nov 2027 · Phase 2 trial completes | ||||
| Also tested for | Advanced Lung Cancer, Advanced Malignant Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 15 Dec 2026soonPhase 1 trial completes | |||
| Next date | 15 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Malignant Solid Tumors | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev